JAGX / Jaguar Health, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Jaguar Health, Inc.

Deler fremragende 401,265 shares
Insideraktier326.193 shares
Insider ejerskab81,29 %
Total Insiders33
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
5592 out of 10945

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
5599 out of 10814

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Jaguar Health, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Ari Azhir 39.286
James J Bochnowski Director - [D] 6.415 183
Bvcf Iii, L.p. 10% Owner - [10%] 1.522.881 37.668
Bvcf Iii-a, L.p. 10% Owner - [10%] 1.522.881 37.668
BVCF Management, Ltd. 10% Owner - [10%] 1.522.881 37.668
Philippe Brianceau 20.000
Bryan Ezralow 1994 Trust dated December 22, 1994 10% Owner - [10%] 2.916.667 65.299
Capital Ltd Burford 10% Owner - [10%] 0 0
Lisa A Conte See Remarks, Director - [D] [O] 29.258 836
Pravin R Chaturvedi Chief Scientific Officer - [O] 11.938 341
Greg J Divis Director - [D] 12.133 249
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Bryan Ezralow 10% Owner - [10%] 2.916.667 65.299
Jonathan M Glaser - 720.405 16.128
Michael Hauser 73.000
Johnson Jeffery C. 121.573
Anula Jayasuriya Director - [D] 5.916 169
John A Kallassy 13.365
Kamphuis Folkert W. 53.164
King Steven R. See Remarks - [O] 11.885 340
Kunlun Pharmaceuticals, Ltd. 10% Owner - [10%] 1.522.881 37.668
Lincoln Alternative Strategies LLC 10% Owner - [10%] 1.200.000 34.286
Lizak Carol R. Chief Financial Officer - [O] 11.911 340
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
John Micek Director - [D] 7.430 212
Murray David MacNaughtan 121.573
Napo Pharmaceuticals Inc 10% Owner - [10%] 5.333.332 131.920
Nantucket Investments Ltd 10% Owner - [10%] 0 0
Jiahao Qiu 12.965
Sagard Capital Partners, L.P. 5.524.926
Siegel Jonathan B. Director - [D] 7.423 212
Waltzman Roger J. 2.866
Wolin Jonathan S. See Remarks - [O] 11.938 341
Karen Steil Wright 303.932
Zhi Yang Director, 10% Owner - [D] [10%] 1.522.881 37.668

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i JAGX / Jaguar Health, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-12-31 Wolin Jonathan S. 317 0,0300 7 1,4625 10 11 519.75 3.110 34.550,00
2021-09-13 CONTE LISA A 7.968 2,5100 163 122,3625 20.000
2021-09-13 Lizak Carol R. 7.968 2,5100 163 122,3625 20.000
2019-07-23 BOCHNOWSKI JAMES J 180.582 2,0000 4.560 79,2000 361.164
2019-07-23 Siegel Jonathan B. 12.705 2,0000 321 79,2000 25.410

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

JAGX / Jaguar Health, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i JAGX / Jaguar Health, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2021-06-04 BOCHNOWSKI JAMES J 152 1,7400 4 68,9040 264 364 1551.6 4.391 1.663,18
2021-06-03 BOCHNOWSKI JAMES J 292 1,7500 7 69,3000 511
2018-09-25 Nantucket Investments Ltd 325.615 1,8300 7.290 81,7400 595.875
2018-09-25 Nantucket Investments Ltd 270.270 1,8300 6.051 81,7400 494.594

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

JAGX / Jaguar Health, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-03-12 2025-12-11 4 MICEK JOHN JAGX Common Stock A - Award D 7.377 7.430
2026-01-21 2025-12-11 4 Wolin Jonathan S. JAGX Common Stock A - Award D 11.740 11.938
2026-01-21 2025-12-11 4 CONTE LISA A JAGX Common Stock A - Award D 28.592 29.258
2026-01-21 2025-12-11 4 King Steven R. JAGX Common Stock A - Award D 11.740 11.885
2025-12-15 2025-12-11 4 Chaturvedi Pravin R JAGX Common Stock A - Award D 11.740 11.938
2025-12-15 2025-12-11 4 BOCHNOWSKI JAMES J JAGX Common Stock A - Award D 6.363 6.415
2025-12-15 2025-12-11 4 Siegel Jonathan B. JAGX Common Stock A - Award D 7.377 7.423
2025-12-15 2025-12-11 4 Jayasuriya Anula JAGX Common Stock A - Award D 5.870 5.916
2025-12-15 2025-12-11 4 Lizak Carol R. JAGX Common Stock A - Award D 11.740 11.911
2025-08-29 3 Lincoln Alternative Strategies LLC JAGX Common Stock, par value $0.0001 per share D 600.000
2025-05-20 2025-05-17 4 CONTE LISA A JAGX Common Stock M - Exercise D 2 666
2025-05-20 2025-05-17 4 King Steven R. JAGX Common Stock M - Exercise D 1 145
2024-10-10 2024-10-08 4 Lizak Carol R. JAGX Common Stock A - Award D 4.280 4.297
2024-10-10 2024-10-08 4 Wolin Jonathan S. JAGX Common Stock A - Award D 4.922 4.955
2024-10-10 2024-10-08 4 Chaturvedi Pravin R JAGX Common Stock A - Award D 4.922 4.957
2024-10-10 2024-10-08 4 CONTE LISA A JAGX Common Stock A - Award D 16.503 16.624
2024-10-10 2024-10-08 4 King Steven R. JAGX Common Stock A - Award D 4.922 4.951
2024-05-21 2024-05-17 4 Wolin Jonathan S. JAGX Common Stock M - Exercise D 871 2.012
2024-05-21 2024-05-17 4 Chaturvedi Pravin R JAGX Common Stock M - Exercise D 871 2.141
2024-05-21 2024-05-17 4 Lizak Carol R. JAGX Common Stock M - Exercise D 431 1.042
2024-05-21 2024-05-17 4 King Steven R. JAGX Common Stock M - Exercise D 612 1.756
2024-05-21 2024-05-17 4 CONTE LISA A JAGX Common Stock M - Exercise D 2.695 7.295
2024-04-17 2024-04-05 4 Chaturvedi Pravin R JAGX Common Stock M - Exercise D 134 1.270
2024-04-17 2024-04-05 4 Lizak Carol R. JAGX Common Stock M - Exercise D 60 611
2024-04-17 2024-04-05 4 Wolin Jonathan S. JAGX Common Stock M - Exercise D 89 1.141
2024-04-17 2024-04-05 4 King Steven R. JAGX Common Stock M - Exercise D 178 1.144
2024-04-17 2024-04-05 4 CONTE LISA A JAGX Common Stock M - Exercise D 600 4.600
2023-08-14 2023-08-14 4 Siegel Jonathan B. JAGX Common Stock A - Award D 68.568 69.874
2023-08-14 2023-08-14 4 MICEK JOHN JAGX Common Stock A - Award D 68.568 80.701
2023-08-14 2023-08-14 4 BOCHNOWSKI JAMES J JAGX Common Stock A - Award D 76.613 78.876
2023-08-14 2023-08-14 4 CONTE LISA A JAGX Common Stock A - Award D 383.605 387.605
2023-08-14 2023-08-14 4 King Steven R. JAGX Common Stock A - Award D 159.168 160.133
2023-08-14 2023-08-14 4 Lizak Carol R. JAGX Common Stock A - Award D 142.088 142.745
2023-08-14 2023-08-14 4 Wolin Jonathan S. JAGX Common Stock A - Award D 196.628 197.680
2023-08-14 2023-08-14 4 Jayasuriya Anula JAGX Common Stock A - Award D 68.568 70.286
2023-08-14 2023-07-01 4 Jayasuriya Anula JAGX Common Stock A - Award D 1.718 1.718
2023-08-14 2023-08-14 4 Chaturvedi Pravin R JAGX Common Stock A - Award D 204.192 205.328
2023-05-19 2023-05-17 4 Chaturvedi Pravin R JAGX Common Stock M - Exercise D 870 1.136
2023-05-19 2023-04-05 4/A Chaturvedi Pravin R JAGX Common Stock M - Exercise D 133 266
2023-05-19 2022-04-05 4/A Chaturvedi Pravin R JAGX Common Stock M - Exercise D 10.000 10.000
2023-05-19 2023-05-17 4 MICEK JOHN JAGX Common Stock M - Exercise D 1.145 1.306
2023-05-19 2023-05-17 4 Siegel Jonathan B. JAGX Common Stock M - Exercise D 1.145 1.306
2023-05-19 2023-05-17 4 BOCHNOWSKI JAMES J JAGX Common Stock M - Exercise D 1.280 2.263
2023-05-19 2023-05-17 4 King Steven R. JAGX Common Stock M - Exercise D 611 965
2023-05-19 2023-05-17 4 Lizak Carol R. JAGX Common Stock M - Exercise D 431 657
2023-05-19 2023-05-17 4 Wolin Jonathan S. JAGX Common Stock M - Exercise D 871 1.052
2023-05-19 2023-05-17 4 CONTE LISA A JAGX Common Stock M - Exercise D 2.694 4.000
2023-04-20 2023-04-05 4 Lizak Carol R. JAGX Common Stock M - Exercise D 60 226
2023-04-20 2023-04-05 4 Chaturvedi Pravin R JAGX Common Stock M - Exercise D 44 88
2023-04-20 2023-04-05 4 Wolin Jonathan S. JAGX Common Stock M - Exercise D 88 181
2023-04-20 2023-04-05 4 King Steven R. JAGX Common Stock M - Exercise D 177 354
2023-04-20 2023-04-05 4 CONTE LISA A JAGX Common Stock M - Exercise D 600 1.306
2023-01-03 2022-12-31 4 Wolin Jonathan S. JAGX Common Stock P - Purchase D 0,0300 317 0 6.983
2022-05-18 2022-05-18 4 BOCHNOWSKI JAMES J JAGX Restricted stock units M - Exercise D -13.133 0
2022-05-18 2022-05-18 4 BOCHNOWSKI JAMES J JAGX Common Stock M - Exercise D 13.133 73.765
2022-05-18 2022-05-18 4 Siegel Jonathan B. JAGX Restricted stock units M - Exercise D -12.133 0
2022-05-18 2022-05-18 4 Siegel Jonathan B. JAGX Common Stock M - Exercise D 12.133 12.133
2022-05-18 2022-05-18 4 DIVIS GREG J JAGX Restricted stock units M - Exercise D -12.133 0
2022-05-18 2022-05-18 4 DIVIS GREG J JAGX Common Stock M - Exercise D 12.133 12.133
2022-05-18 2022-05-18 4 MICEK JOHN JAGX Restricted stock units M - Exercise D -12.133 0
2022-05-18 2022-05-18 4 MICEK JOHN JAGX Common Stock M - Exercise D 12.133 12.133
2022-04-06 2022-04-05 4 Chaturvedi Pravin R JAGX Restricted stock units A - Award D 3.333 6.666
2022-04-06 2022-04-05 4 Chaturvedi Pravin R JAGX Common Stock M - Exercise D 3.333 3.333
2022-04-06 2022-04-05 4 Lizak Carol R. JAGX Restricted stock units A - Award D 4.513 9.028
2022-04-06 2022-04-05 4 Lizak Carol R. JAGX Common Stock M - Exercise D 4.513 12.481
2022-04-06 2022-04-05 4 Wolin Jonathan S. JAGX Restricted stock units A - Award D 6.666 13.333
2022-04-06 2022-04-05 4 Wolin Jonathan S. JAGX Common Stock M - Exercise D 6.666 6.666
2022-04-06 2022-04-05 4 CONTE LISA A JAGX Restricted stock units A - Award D 45.000 90.000
2022-04-06 2022-04-05 4 CONTE LISA A JAGX Common Stock M - Exercise D 45.000 53.003
2022-04-06 2022-04-05 4 King Steven R. JAGX Restricted stock units A - Award D 13.333 26.666
2022-04-06 2022-04-05 4 King Steven R. JAGX Common Stock M - Exercise D 13.333 13.333
2022-03-30 2022-03-28 4 DIVIS GREG J JAGX Restricted stock units A - Award D 85.900 85.900
2022-03-30 2022-03-28 4 Siegel Jonathan B. JAGX Restricted stock units A - Award D 85.900 85.900
2022-03-30 2022-03-28 4 MICEK JOHN JAGX Restricted stock units A - Award D 85.900 85.900
2022-03-30 2022-03-28 4 BOCHNOWSKI JAMES J JAGX Restricted stock units A - Award D 96.015 96.015
2022-03-30 2022-03-28 4 Chaturvedi Pravin R JAGX Restricted stock units A - Award D 195.934 195.934
2022-03-30 2022-03-28 4 Lizak Carol R. JAGX Restricted stock units A - Award D 97.025 97.025
2022-03-30 2021-09-13 4 Lizak Carol R. JAGX Common Stock P - Purchase I 2,5100 7.968 20 7.968
2022-03-30 2022-03-28 4 Wolin Jonathan S. JAGX Restricted stock units A - Award D 196.018 196.018
2022-03-30 2022-03-28 4 King Steven R. JAGX Restricted stock units A - Award D 137.685 137.685
2022-03-30 2022-03-28 4 CONTE LISA A JAGX Restricted stock units A - Award D 25.000 25.000
2022-03-30 2022-03-28 4 CONTE LISA A JAGX Restricted stock units A - Award D 606.280 606.280
2022-03-30 2021-09-13 4 CONTE LISA A JAGX Common Stock P - Purchase D 2,5100 7.968 20 8.003
2021-06-07 2021-06-04 4 BOCHNOWSKI JAMES J JAGX Common Stock S - Sale D 1,7400 -152 -0 954.390
2021-06-07 2021-06-03 4 BOCHNOWSKI JAMES J JAGX Common Stock S - Sale D 1,7500 -292 -1 954.542
2021-05-20 2021-05-18 4 Siegel Jonathan B. JAGX Restricted stock units A - Award D 36.400 36.400
2021-05-20 2021-05-18 4 Siegel Jonathan B. JAGX Stock option (right to buy) A - Award D 1,24 72.750 72.750
2021-05-20 2021-05-18 4 MICEK JOHN JAGX Restricted stock units A - Award D 36.400 36.400
2021-05-20 2021-05-18 4 MICEK JOHN JAGX Stock option (right to buy) A - Award D 1,24 72.750 72.750
2021-05-20 2021-05-18 4 DIVIS GREG J JAGX Restricted stock units A - Award D 36.400 36.400
2021-05-20 2021-05-18 4 DIVIS GREG J JAGX Stock option (right to buy) A - Award D 1,24 72.750 72.750
2021-05-20 2021-05-18 4 BOCHNOWSKI JAMES J JAGX Restricted stock units A - Award D 39.400 39.400
2021-05-20 2021-05-18 4 BOCHNOWSKI JAMES J JAGX Stock option (right to buy) A - Award D 1,24 78.750 78.750
2021-04-07 2021-04-05 4 Lizak Carol R. JAGX Restricted stock units A - Award D 40.625 40.625
2021-04-07 2021-04-05 4 Lizak Carol R. JAGX Stock option (right to buy) A - Award D 1,99 81.250 81.250
2021-04-07 2021-04-05 4 Wolin Jonathan S. JAGX Restricted stock units A - Award D 60.000 60.000
2021-04-07 2021-04-05 4 Wolin Jonathan S. JAGX Stock option (right to buy) A - Award D 1,99 120.000 120.000
2021-04-07 2021-04-05 4 King Steven R. JAGX Restricted stock units A - Award D 120.000 120.000
2021-04-07 2021-04-05 4 King Steven R. JAGX Stock option (right to buy) A - Award D 1,99 240.000 240.000
2021-04-07 2021-04-05 4 CONTE LISA A JAGX Restricted stock units A - Award D 405.000 405.000
2021-04-07 2021-04-05 4 CONTE LISA A JAGX Stock option (right to buy) A - Award D 1,99 810.000 810.000
2020-03-25 2020-03-20 4 BOCHNOWSKI JAMES J JAGX Stock Option (right to buy) A - Award D 0,45 45.486 45.486
2020-03-24 2020-03-20 4 Lizak Carol R. JAGX Stock Option (right to buy) A - Award D 0,45 50.000 50.000
2020-03-24 2020-03-20 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 0,45 79.431 79.431
2020-03-24 2020-03-20 4 MICEK JOHN JAGX Stock Option (right to buy) A - Award D 0,45 26.533 26.533
2020-03-24 2020-03-20 4 Siegel Jonathan B. JAGX Stock Option (right to buy) A - Award D 0,45 45.486 45.486
2020-03-24 2020-03-20 4 Wolin Jonathan S. JAGX Stock Option (right to buy) A - Award D 0,45 59.753 59.753
2020-03-24 2020-03-20 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 0,45 238.293 238.293
2020-03-24 2020-03-20 4 DIVIS GREG J JAGX Stock option (right to buy) A - Award D 0,45 26.533 26.533
2019-07-26 2019-07-24 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 1,73 347.351 347.351
2019-07-26 2019-07-24 4 DIVIS GREG J JAGX Stock Option (right to buy) A - Award D 1,73 121.573 121.573
2019-07-26 2019-07-24 4 JOHNSON JEFFERY C. JAGX Stock Option (right to buy) A - Award D 1,73 121.573 121.573
2019-07-26 2019-07-24 4 MacNaughtan Murray David JAGX Stock Option (right to buy) A - Award D 1,73 121.573 121.573
2019-07-26 2019-07-24 4 MICEK JOHN JAGX Stock Option (right to buy) A - Award D 1,73 121.573 121.573
2019-07-26 2019-07-24 4 Wright Karen Steil JAGX Stock Option (right to buy) A - Award D 1,73 303.932 303.932
2019-07-25 2019-07-24 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 1,73 1.042.052 1.042.052
2019-07-25 2019-06-07 4 CONTE LISA A JAGX Bridge Warrant to Purchase Common Stock P - Purchase D 2,00 37.500 37.500
2019-07-25 2019-07-24 4 BOCHNOWSKI JAMES J JAGX Stock Option (right to buy) A - Award D 1,73 208.410 208.410
2019-07-25 2019-07-23 4 BOCHNOWSKI JAMES J JAGX Series 2 Warrant to Purchase Common Stock P - Purchase I 2,00 180.582 180.582
2019-07-25 2019-07-23 4 BOCHNOWSKI JAMES J JAGX Series 1 Warrant to Purchase Common Stock P - Purchase I 2,00 180.582 180.582
2019-07-25 2019-07-23 4 BOCHNOWSKI JAMES J JAGX Common Stock P - Purchase I 2,0000 180.582 361 181.618
2019-07-25 2019-05-24 4 BOCHNOWSKI JAMES J JAGX Bridge Warrant to Purchase Common Stock P - Purchase I 2,00 218.750 218.750
2019-07-25 2019-07-24 4 Siegel Jonathan B. JAGX Stock Option (right to buy) A - Award D 1,73 208.410 208.410
2019-07-25 2019-07-23 4 Siegel Jonathan B. JAGX Series 2 Warrant to Purchase Common Stock P - Purchase I 2,00 12.705 12.705
2019-07-25 2019-07-23 4 Siegel Jonathan B. JAGX Series 1 Warrant to Purchase Common Stock P - Purchase I 2,00 12.705 12.705
2019-07-25 2019-07-23 4 Siegel Jonathan B. JAGX Common Stock P - Purchase I 2,0000 12.705 25 13.276
2019-07-25 2019-05-31 4 Siegel Jonathan B. JAGX Bridge Warrant to Purchase Common Stock P - Purchase I 2,00 34.375 34.375
2019-03-15 2019-03-14 4 Sagard Capital Partners, L.P. JAGX Series A Convertible Participating Preferred Stock P - Purchase I 0,28 5.524.926 5.524.926
2019-03-15 2019-03-14 4 Sagard Capital Partners, L.P. JAGX Series A Convertible Participating Preferred Stock H - Other I 2,78 -5.524.926 0
2018-10-24 2018-09-25 4 Nantucket Investments Ltd JAGX Non-Voting Common Stock S - Sale D 1,8300 270.270 495 38.180.451
2018-10-24 2018-09-25 4 Nantucket Investments Ltd JAGX Common Stock S - Sale D 1,8300 -325.615 -596 0
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By EZ MM&B Holdings, LLC JAGX Common Stock I 2.083.334
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By Bryan Ezralow 1994 Trust u/t/d December 22, 1994 JAGX Common Stock I 2.916.667
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By EZ MM&B Holdings, LLC JAGX Common Stock I 2.083.334
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By Bryan Ezralow 1994 Trust u/t/d December 22, 1994 JAGX Common Stock I 2.916.667
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By EZ MM&B Holdings, LLC JAGX Common Stock I 2.083.334
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By Bryan Ezralow 1994 Trust u/t/d December 22, 1994 JAGX Common Stock I 2.916.667
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By EZ MM&B Holdings, LLC JAGX Common Stock I 2.083.334
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By Bryan Ezralow 1994 Trust u/t/d December 22, 1994 JAGX Common Stock I 2.916.667
2018-10-05 2018-10-04 4 Siegel Jonathan B. JAGX Common Stock P - Purchase I 0,6000 25.000 15 40.000
2018-10-04 2018-07-17 4/A Siegel Jonathan B. JAGX Common Stock P - Purchase I 1,1900 268 0 15.000
2018-09-25 2018-09-25 4 GLASER JONATHAN M By Pacific Capital Management, LLC JAGX Common Stock G - Gift I -60.000 720.405
2018-08-03 3 GLASER JONATHAN M By JLA Family Limited Partnership JAGX Common Stock I 938.953
2018-08-03 3 GLASER JONATHAN M By JMG Capital Management LLC 401(k) Profit Sharing Plan JAGX Common Stock I 1.018.001
2018-08-03 3 GLASER JONATHAN M By Pacific Capital Management, LLC JAGX Common Stock I 1.692.858
2018-08-03 3 GLASER JONATHAN M By JLA Family Limited Partnership JAGX Common Stock I 938.953
2018-08-03 3 GLASER JONATHAN M By JMG Capital Management LLC 401(k) Profit Sharing Plan JAGX Common Stock I 1.018.001
2018-08-03 3 GLASER JONATHAN M By Pacific Capital Management, LLC JAGX Common Stock I 1.692.858
2018-08-03 3 GLASER JONATHAN M By JMG Capital Management LLC 401(k) Profit Sharing Plan JAGX Common Stock I 1.018.001
2018-08-03 3 GLASER JONATHAN M By Pacific Capital Management, LLC JAGX Common Stock I 1.692.858
2018-08-03 3 GLASER JONATHAN M By JLA Family Limited Partnership JAGX Common Stock I 938.953
2018-07-20 2018-07-18 4 Siegel Jonathan B. JAGX Common Stock P - Purchase I 1,0952 5.000 5 14.732
2018-07-18 2018-07-18 4 CONTE LISA A JAGX Common Stock P - Purchase D 1,1124 1.500 2 7.500
2018-07-18 2018-07-17 4 Siegel Jonathan B. JAGX Common Stock P - Purchase I 1,1900 2.232 3 9.732
2018-07-18 2018-07-16 4 Siegel Jonathan B. JAGX Common Stock P - Purchase I 1,3586 7.500 10 9.732
2018-07-13 2018-07-11 4 MacNaughtan Murray David JAGX Stock Option (right to buy) A - Award D 1,36 104.860 104.860
2018-07-13 2018-07-11 4 DIVIS GREG J JAGX Stock Option (right to buy) A - Award D 1,36 104.860 104.860
2018-06-06 2018-03-12 4 Qiu Jiahao JAGX Stock Option (right to buy) A - Award D 8,40 12.965 12.965
2018-06-06 2018-03-12 4 Kamphuis Folkert W. JAGX Stock Option (right to buy) A - Award D 8,40 53.164 53.164
2018-06-06 2018-03-12 4 Yang Zhi JAGX Stock Option (right to buy) A - Award D 8,40 12.965 12.965
2018-06-06 2018-03-12 4 Azhir Ari JAGX Stock Option (right to buy) A - Award D 8,40 39.286 39.286
2018-06-06 2018-06-01 4 Wright Karen Steil JAGX Stock Option (right to buy) A - Award D 2,73 85.854 85.854
2018-06-06 2018-06-01 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 2,73 149.311 149.311
2018-06-06 2018-06-01 4 BOCHNOWSKI JAMES J JAGX Stock Option (right to buy) A - Award D 2,39 251.665 251.665
2018-06-06 2018-03-12 4 BOCHNOWSKI JAMES J JAGX Stock Option (right to buy) A - Award D 8,40 71.709 71.709
2018-06-06 2018-06-01 4 MICEK JOHN JAGX Stock Option (right to buy) A - Award D 2,39 146.804 146.804
2018-06-06 2018-03-12 4 MICEK JOHN JAGX Stock Option (right to buy) A - Award D 8,40 38.643 38.643
2018-06-06 2018-06-01 4 Siegel Jonathan B. JAGX Stock Option (right to buy) A - Award D 2,73 104.860 104.860
2018-06-06 2018-06-01 4 JOHNSON JEFFERY C. JAGX Stock Option (right to buy) A - Award D 2,73 104.860 104.860
2018-06-06 2018-06-01 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 2,73 447.935 447.935
2018-03-14 2018-03-12 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 0,56 3.247.242 3.247.242
2018-03-14 2018-03-12 4 Wright Karen Steil JAGX Stock Option (right to buy) A - Award D 0,56 998.857 998.857
2018-03-14 2018-03-12 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 0,56 1.327.881 1.327.881
2017-12-29 2017-12-21 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 0,12 285.807 285.807
2017-12-29 2017-12-21 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 0,12 95.269 95.269
2017-12-29 2017-12-21 4 Wright Karen Steil JAGX Stock Option (right to buy) A - Award D 0,12 54.295 54.295
2017-08-09 3 Nantucket Investments Ltd JAGX Common Stock, par value $0.0001 per share ("Common Stock") D 9.768.490
2017-08-09 3 Nantucket Investments Ltd JAGX Common Stock, par value $0.0001 per share ("Common Stock") D 9.768.490
2017-08-09 3 Nantucket Investments Ltd JAGX Common Stock, par value $0.0001 per share ("Common Stock") D 9.768.490
2017-08-02 2017-06-28 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock P - Purchase I 0,5000 100.000 50 797.935
2016-12-21 2016-12-19 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 0,74 16.998 16.998
2016-12-21 2016-12-19 4 BOCHNOWSKI JAMES J JAGX Stock Option (right to buy) A - Award D 0,74 16.378 16.378
2016-12-21 2016-12-19 4 MICEK JOHN JAGX Stock Option (right to buy) A - Award D 0,74 10.884 10.884
2016-12-21 2016-12-19 4 Wright Karen Steil JAGX Stock Option (right to buy) A - Award D 0,74 2.866 2.866
2016-12-21 2016-12-19 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 0,74 4.496 4.496
2016-12-21 2016-12-19 4 Kamphuis Folkert W. JAGX Stock Option (right to buy) A - Award D 0,74 13.771 13.771
2016-12-21 2016-12-19 4 Waltzman Roger J. JAGX Stock Option (right to buy) A - Award D 0,74 2.866 2.866
2016-11-14 2016-08-12 4 Kamphuis Folkert W. JAGX Stock Option (right to buy) A - Award D 1,47 50.000 50.000
2016-09-26 2016-09-22 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 1,25 23.042 23.042
2016-09-26 2016-09-22 4 Kamphuis Folkert W. JAGX Stock Option (right to buy) A - Award D 1,25 13.000 13.000
2016-09-23 2016-09-22 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 1,25 318.000 318.000
2016-09-23 2016-09-22 4 Wright Karen Steil JAGX Stock Option (right to buy) A - Award D 1,25 103.698 103.698
2016-09-23 2016-09-22 4 BOCHNOWSKI JAMES J JAGX Stock Option (right to buy) A - Award D 1,25 75.000 75.000
2016-08-16 2016-08-12 4 Waltzman Roger J. JAGX Stock Option (right to buy) A - Award D 1,47 127.500 127.500
2016-06-16 2016-06-14 4 CONTE LISA A JAGX Stock option (right to buy) A - Award D 1,58 69.970 69.970
2016-06-16 2016-06-14 4 CONTE LISA A JAGX Stock option (right to buy) A - Award D 4,84 113.212 113.212
2016-06-16 2016-06-14 4 CONTE LISA A JAGX Stock option (right to buy) A - Award D 5,09 85.616 85.616
2016-06-16 2016-06-14 4 BOCHNOWSKI JAMES J JAGX Stock option (right to buy) A - Award D 1,58 11.293 11.293
2016-06-16 2016-06-14 4 Wright Karen Steil JAGX Stock option (right to buy) A - Award D 1,58 3.802 3.802
2016-06-16 2016-06-14 4 Qiu Jiahao JAGX Stock option (right to buy) A - Award D 1,58 1.901 1.901
2016-06-16 2016-06-14 4 King Steven R. JAGX Stock option (right to buy) A - Award D 1,58 28.263 28.263
2016-06-16 2016-06-14 4 King Steven R. JAGX Stock option (right to buy) A - Award D 5,09 49.942 49.942
2016-06-16 2016-06-14 4 Yang Zhi JAGX Stock option (right to buy) A - Award D 1,58 1.901 1.901
2016-06-16 2016-06-14 4 Kamphuis Folkert W. JAGX Stock option (right to buy) A - Award D 1,58 9.504 9.504
2016-04-05 2016-04-01 4 Brianceau Philippe JAGX Stock Option (right to buy) A - Award D 1,58 20.000 20.000
2016-02-09 2016-02-08 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock P - Purchase I 2,5000 160.000 400 487.576
2015-06-04 2015-06-02 4 BOCHNOWSKI JAMES J JAGX Stock option (right to buy) A - Award D 6,70 20.000 20.000
2015-06-04 2015-06-02 4 Qiu Jiahao JAGX Stock option (right to buy) A - Award D 6,70 10.000 10.000
2015-06-04 2015-06-02 4 Yang Zhi JAGX Stock option (right to buy) A - Award D 6,70 10.000 10.000
2015-06-04 2015-06-02 4 Kamphuis Folkert W. JAGX Stock option (right to buy) A - Award D 6,70 50.000 50.000
2015-05-18 2015-05-18 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Convertible Promissory Note C - Conversion I 5,60 0
2015-05-18 2015-05-18 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Series A Preferred Stock C - Conversion I -224.499 0
2015-05-18 2015-05-18 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Convertible Promissory Note C - Conversion I 5,60 0
2015-05-18 2015-05-18 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock C - Conversion I 5,6000 44.642 250 327.576
2015-05-18 2015-05-18 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock C - Conversion I 5,6000 35.714 200 282.934
2015-05-18 2015-05-18 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock C - Conversion I 148.332 247.220
2015-05-18 2015-05-18 4 Kallassy John A JAGX Stock Option (right to buy) A - Award D 7,00 13.365 13.365
2015-05-18 2015-05-18 4 Yang Zhi By Kunlun Pharmaceuticals, Ltd. JAGX Series A Preferred Stock C - Conversion I -2.224.991 0
2015-05-18 2015-05-18 4 Yang Zhi JAGX Common Stock C - Conversion I 1.483.326 1.522.881
2015-05-18 2015-05-18 4 BVCF Management, Ltd. By Kunlun Pharmaceuticals, Ltd. JAGX Series A Preferred Stock C - Conversion I -2.224.991 0
2015-05-18 2015-05-18 4 BVCF Management, Ltd. JAGX Common Stock C - Conversion I 1.483.326 1.522.881
2015-05-18 2015-05-18 4 Hauser Michael JAGX Stock Option (right to buy) A - Award D 7,00 73.000 73.000
2015-05-13 3 BVCF III-A, L.P. By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 BVCF III-A, L.P. By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 BVCF III-A, L.P. By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 BVCF III-A, L.P. By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 BVCF III-A, L.P. By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 NAPO PHARMACEUTICALS INC JAGX Common Stock D 5.333.332
2015-05-13 3 NAPO PHARMACEUTICALS INC JAGX Common Stock D 5.333.332
2015-05-13 3 Yang Zhi By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 Yang Zhi By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock I 197.776
2015-05-13 3 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock I 197.776
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Other Listings
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista